- Mahindra’s automotive sales for January 2025 totaled 85,432 units, representing a 16% increase compared to the previous year.
- Overall sales growth was 16%, up slightly from 15% the year before.
- Commercial vehicle sales reached 23,917 units, showing a modest growth of 1.9% year-on-year.
- Tractor sales saw a robust increase, totaling 26,305 units, which is a 15% rise from the previous year.
- Tractor exports grew significantly by 28%, amounting to 1,252 units.
- Investor sentiment indicates 36 buy recommendations, 4 hold, and 1 sell.
A look at Mahindra & Mahindra Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 4 | |
| Growth | 4 | |
| Resilience | 2 | |
| Momentum | 5 | |
| OVERALL SMART SCORE | 3.6 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Investors looking at the long-term outlook for Mahindra & Mahindra can find insights through Smartkarma’s Smart Scores. With a solid score of 4 for both Dividend and Growth, the company shows promising signs for potential returns and expansion. In addition, Momentum is rated at an impressive 5, indicating strong market performance and positive investor sentiment. Although Value scores a respectable 3, Resilience lags behind at 2, suggesting a potential area of improvement for the company.
As a leading manufacturer of automobiles, farm equipment, and automotive components, Mahindra & Mahindra Ltd. has established itself as a key player in the industry. The company’s diverse product range includes commercial vehicles, passenger cars, agricultural tractors, internal combustion engines, and more. With favorable scores in Dividend, Growth, and Momentum, Mahindra & Mahindra appears well-positioned for future growth and success in the market.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
